Home » Topics » Conferences

Conferences
RSS

First clinical trials performed with BMS-181885

April 7, 1998

Phase Ib results reported for allosteric Hb modifier RSR13

April 7, 1998

Novel antisecretory/antiulcer agent from Shionogi undergoes evaluation in Japan

April 7, 1998

YM-905 shows promising activity in animal model of IBS

April 6, 1998

YM-905 shows promise as safe and effective treatment for overactive detrusor

April 6, 1998

Genetronics' EPT plus bleomycin looks effective in prostate cancer

April 6, 1998

Antiplatelet and antithrombotic effects of FR-171113 in guinea pigs

April 6, 1998

Leukocyte activation inhibitor active in animal models of myocardial infarction

April 6, 1998

Prostate cancer immunotherapeutic evaluated in preclinical and clinical trials

April 6, 1998

RS-100975, a prostate-selective alpha-blocker in vitro

April 6, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 12, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 9, 2026
Pre-disease plasma signature may help redefine lung cancer risk
BioWorld
Researchers have identified a 14-protein blood signature that can predict lung cancer risk as much as five years before diagnosis, and the findings could help...
Europe’s Alzecure, Orionis in $1B+ deals with Lilly, Novartis
BioWorld
Two companies with European ties signed billion-dollar deals with large pharma firms in the last two days to discover and develop molecular glue drugs, as well as...
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...